Dan A. Giampuzzi

Dan A. Giampuzzi

Geen lopende functies

Health Technology
Consumer Services
Finance

Profiel

Mr. Giampuzzi most recently served as President and CEO of Gemin X Biotechnologies Inc., a Montreal/Philadelphia-based private biotechnology company that specializes in the discovery and development of novel small molecule cancer therapeutics based on the regulation of apoptosis, the body's natural ability to destroy injured or damaged cells.
During his nine years at Gemin X, he successfully raised over $100 million in private venture capital financing from international firms and assembled a highly capable team that has put over 12 cancer drugs into the clinic and six onto the market today.
Previous to Gemin X he worked in senior management roles for such organizations as MDS Capital Corp., Searle Canada Inc. and Merrell Dow Pharmaceuticals.
Mr. Giampuzzi earned a Bachelor of Science and an MBA from the University of Toronto.

Eerdere bekende functies van Dan A. Giampuzzi

BedrijvenFunctieEinde
Private Equity Investor 01-12-2008
President 31-07-2007
Ervaring van Dan A. Giampuzzi in detail bekijken

Opleiding van Dan A. Giampuzzi

University of Toronto Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Dan A. Giampuzzi in detail bekijken

Connecties

17

Eerstegraads connecties

3

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit2

Health Technology

Finance

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Dan A. Giampuzzi